🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.

Several experts stated the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on the social media company, the service has taken down problematic material and banned associated hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home.

Within moments of entering one community, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or past usage.

Item Details and Pricing

Inside these communities, posts show black plastic packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious medical dangers”.